Plant extracts’ in vitro anti-obesity potential is often assessed by evaluating their inhibitory activities against pancreatic lipase, alpha-glucosidase, alpha-amylase, and fatty acid synthase enzymes (discussed above). Here, FASN is linked to obesity due to melanocortin 4 receptor deficiency.